These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 39370730)

  • 1. Jolkinolide B Ameliorates Liver Inflammation and Lipogenesis by Regulating JAK/STAT3 Pathway.
    Noh HR; Sui G; Lee JW; Wang F; Park JS; Ma Y; Ma H; Jeong JW; Shin DS; Wu X; Hwang BY; Roh YS
    Biomol Ther (Seoul); 2024 Nov; 32(6):793-800. PubMed ID: 39370730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jolkinolide B ameliorates rheumatoid arthritis by regulating the JAK2/STAT3 signaling pathway.
    Yan Y; Zhang LB; Ma R; Wang MN; He J; Wang PP; Tao QW; Xu Y
    Phytomedicine; 2024 Feb; 124():155311. PubMed ID: 38199156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jolkinolide A and Jolkinolide B Inhibit Proliferation of A549 Cells and Activity of Human Umbilical Vein Endothelial Cells.
    Shen L; Zhang SQ; Liu L; Sun Y; Wu YX; Xie LP; Liu JC
    Med Sci Monit; 2017 Jan; 23():223-237. PubMed ID: 28087861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRUCE liver-deficiency potentiates MASLD/MASH in PTEN liver-deficient background by impairment of mitochondrial metabolism in hepatocytes and activation of STAT3 signaling in hepatic stellate cells.
    Che L; Stevenson CK; Plas DR; Wang J; Du C
    bioRxiv; 2024 Sep; ():. PubMed ID: 39314445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jolkinolide B attenuates allergic airway inflammation and airway remodeling in asthmatic mice.
    Lin H; Xu C; Ge J; Wu H; Wang Q
    Allergol Immunopathol (Madr); 2024; 52(4):91-96. PubMed ID: 38970271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linalool attenuates lipid accumulation and oxidative stress in metabolic dysfunction-associated steatotic liver disease via Sirt1/Akt/PPRA-α/AMPK and Nrf-2/HO-1 signaling pathways.
    Tamilmani P; Sathibabu Uddandrao VV; Chandrasekaran P; Saravanan G; Brahma Naidu P; Sengottuvelu S; Vadivukkarasi S
    Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102231. PubMed ID: 37865226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial antiviral signaling protein enhances MASLD progression through the ERK/TNFα/NFκβ pathway.
    Nóvoa E; da Silva Lima N; Gonzalez-Rellan MJ; Chantada-Vazquez MDP; Verheij J; Rodriguez A; Esquinas-Roman EM; Fondevila MF; Koning M; Fernandez U; Cabaleiro A; Parracho T; Iglesias-Moure J; Seoane S; Porteiro B; Escudero A; Senra A; Perez-Fernandez R; López M; Fidalgo M; Guallar D; Martinez-Chantar ML; Dieguez C; Varela-Rey M; Prevot V; Schwaninger M; Meijnikman A; Bravo SB; Frühbeck G; Nogueiras R
    Hepatology; 2024 May; ():. PubMed ID: 38761407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jolkinolide B from Euphorbia fischeriana Steud induces in human leukemic cells apoptosis via JAK2/STAT3 pathways.
    Wang JH; Zhang K; Niu HY; Shu LH; Yue DM; Li D; He P
    Int J Clin Pharmacol Ther; 2013 Mar; 51(3):170-8. PubMed ID: 23253949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
    Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
    Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of Jolkinolide B on LPS-induced mouse acute lung injury.
    Yang H; Li Y; Huo P; Li XO; Kong D; Mu W; Fang W; Li L; Liu N; Fang L; Li H; He C
    Int Immunopharmacol; 2015 May; 26(1):119-24. PubMed ID: 25819665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line.
    Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N
    J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jolkinolide B induces apoptosis of colorectal carcinoma through ROS-ER stress-Ca
    Zhang J; Wang Y; Zhou Y; He QY
    Oncotarget; 2017 Oct; 8(53):91223-91237. PubMed ID: 29207638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jolkinolide B Inhibits Gastric Cancer Growth by Targeting the PANoptosis Molecular Switch Caspase-8.
    Ma C; Gao L; Song K; Gu B; Wang B; Pu W; Chen H
    J Cancer; 2024; 15(18):6038-6051. PubMed ID: 39440048
    [No Abstract]   [Full Text] [Related]  

  • 15. Cysteine-rich 61 inhibition attenuates hepatic insulin resistance and improves lipid metabolism in high-fat diet fed mice and HepG2 cells.
    Heo YJ; Park J; Lee N; Choi SE; Jeon JY; Han SJ; Kim DJ; Lee KW; Kim HJ
    FASEB J; 2024 Aug; 38(15):e23859. PubMed ID: 39082187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury.
    Horiguchi N; Wang L; Mukhopadhyay P; Park O; Jeong WI; Lafdil F; Osei-Hyiaman D; Moh A; Fu XY; Pacher P; Kunos G; Gao B
    Gastroenterology; 2008 Apr; 134(4):1148-58. PubMed ID: 18395093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting acetyl-CoA carboxylases for the treatment of MASLD.
    Mateo-Marín MA; Alves-Bezerra M
    J Lipid Res; 2024 Dec; 65(12):100676. PubMed ID: 39461620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Novel Mechanistic Insights.
    Aggeletopoulou I; Tsounis EP; Triantos C
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH.
    Liu YJ; Kimura M; Li X; Sulc J; Wang Q; Rodríguez-López S; Scantlebery AML; Strotjohann K; Gallart-Ayala H; Vijayakumar A; Myers RP; Ivanisevic J; Houtkooper RH; Subramanian GM; Takebe T; Auwerx J
    J Hepatol; 2024 Aug; ():. PubMed ID: 39181211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotic Mixture Ameliorates a Diet-Induced MASLD/MASH Murine Model through the Regulation of Hepatic Lipid Metabolism and the Gut Microbiome.
    Zhang F; Lo EKK; Chen J; Wang K; Felicianna ; Ismaiah MJ; Leung HKM; Zhao D; Lee JC; El-Nezami H
    J Agric Food Chem; 2024 Apr; 72(15):8536-8549. PubMed ID: 38575146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.